Context Therapeutics Inc. (NasdaqCM: CNTX)
Health Care · Pharmaceuticals · US
$0.30
-1.78% today · -78.4% 1Y
Context Therapeutics Inc. (NasdaqCM: CNTX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $27.95M and employs 15 people.
Over the last twelve months the share price has lost 78.4%, trading between 0.30 and 3.62.
Tweenvest scores Context Therapeutics Inc. across four factors: quality 45/100, value 30/100. Its strongest factor is quality.
CNTX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $27.95M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.48
- Dividend yield
- —
- Beta (5Y)
- 1.72
- 52-week high
- $3.62
- 52-week low
- $0.30
- Avg volume (3M)
- —
- Shares outstanding
- 91.88M
- Employees
- 15
- Next earnings
- —
About Context Therapeutics Inc.
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
- ISIN
- US21077P1084
- Founded
- 2015
- Listed since
- Oct 20, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Kyung Nam Pharm Co.,Ltd.KOSDAQ: A053950 | $29.17M | ₩1,999.00 | +0.15% |
| IGC Pharma, Inc.NYSEAM: IGC | $28.94M | $0.28 | +1.82% |
| Extrawell Pharmaceutical Holdings LimitedSEHK: 858 | $28.45M | HK$0.08 | -3.75% |
| ZYUS Life Sciences CorporationTSXV: ZYUS | $28.22M | CA$0.50 | -16.67% |
| Vidipha Central Pharmaceutical Joint Stock CompanyHOSE: VDP | $27.81M | ₫32,600.00 | -20.20% |
| BDH Industries LimitedBSE: 524828 | $27.69M | Rs465.55 | -3.45% |
| SymBio Pharmaceuticals LimitedTSE: 4582 | $27.34M | ¥54.00 | -3.57% |
| Seach Medical Group LtdTASE: SEMG | $27.26M | ₪2.60 | -7.71% |
Figures last refreshed Oct 11, 2026.